The sensitivity of domestic animal cell lines to eight recombinant human interferons. 1988

R Bridgman, and C R Rossi, and M Campos
Animal Health Research, Alabama Agricultural Experiment Station, Auburn.

The biological activities of eight recombinant human interferons (IFNs) were tested on permanent cell lines and low-passage embryonic cultures from domestic animal tissues. Each titer was compared to its titer on Madin-Darby bovine kidney (MDBK) cells. Although different cells within a species had different sensitivities to different IFNs, the order of sensitivity, in general, was ox, sheep, pig, cat, horse, and dog, the latter being quite insensitive to most IFNs.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D014762 Viral Interference A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus. Interference, Viral,Interferences, Viral,Viral Interferences

Related Publications

R Bridgman, and C R Rossi, and M Campos
January 1987, Differentiation; research in biological diversity,
R Bridgman, and C R Rossi, and M Campos
January 1983, Journal of interferon research,
R Bridgman, and C R Rossi, and M Campos
January 1984, Journal of interferon research,
R Bridgman, and C R Rossi, and M Campos
September 1983, The Journal of general virology,
R Bridgman, and C R Rossi, and M Campos
January 1985, Arzneimittel-Forschung,
R Bridgman, and C R Rossi, and M Campos
May 1993, In vitro cellular & developmental biology. Animal,
R Bridgman, and C R Rossi, and M Campos
April 2013, The Journal of general virology,
R Bridgman, and C R Rossi, and M Campos
May 2010, Cancer chemotherapy and pharmacology,
R Bridgman, and C R Rossi, and M Campos
February 1986, The Japanese journal of experimental medicine,
R Bridgman, and C R Rossi, and M Campos
October 1996, Journal of virology,
Copied contents to your clipboard!